Market Size of Global Saliva Collection and Diagnosis Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 10.10 % |
| Fastest Growing Market | North America |
| Largest Market | Asia-Pacific |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Saliva Collection and Diagnostics Market Analysis
The saliva collection and diagnosis market are projected to register a CAGR of 10.1% during the forecast period (2022-2027).
COVID-19 has had a significant impact on the growth of the market, owing to the rising cases of infectious diseases among people and an increased preference for non-invasive and self-saliva-based tests. The increase in the need to diagnose COVID-19 infected patients created lucrative opportunities for the saliva collection and diagnosis market. For instance, according to the World Health Organization (WHO), in January 2022, the number of new COVID-19 cases increased by 5% across the globe from January 17th to January 23rd, 2022. Additionally, initiatives taken by the market players also contributed to the growth of the market. For instance, in December 2021, Cotipharma launched a saliva-based Omicron detecting PCR test in Africa. This test is CE-marked and can detect all known variants of SARS-CoV-2, including Omicron. Thus, COVID-19 is expected to have a significant impact on the growth of the market.
Furthermore, the increasing prevalence of infectious diseases among people across the globe is assumed to be one of the major driving factors for market growth. According to the World Health Organization (WHO), in 2021, 60% of the global population suffered from infectious diseases. The report also stated that infectious diseases kill over 17 million people a year, which illustrates the global burden of infectious diseases. The rise in the number of infectious cases has led to the demand for safe and effective diagnostic tests and products. Hence, saliva collection and diagnosis play a major role as a non-invasive diagnostic method for screening patients for several diseases.
Moreover, the increase in product approvals for saliva collection and diagnostic products is a significant factor likely to augment the market's growth. For instance, in July 2021, Hologic Inc.'s HOLX optima SARS-COV-2 molecular diagnostic test received CE marking by the European Union for its use with a saliva sample.
Additionally, the initiatives taken by the public authorities are also propelling the growth of the market. For instance, in August 2022, Australia launched one of the world's first preventative DNA screening programs for cancer and heart disease risk through free DNA saliva tests. It is a nationally collaborative project, led by Australia's Monash University. Furthermore, the initiatives taken by market players to support labs in conducting scientific studies using banked saliva samples, taking advantage of a sample type that is easy to access and non-invasive, are expected to have a positive impact on the growth of the market. For instance, in September 2021, Thermo Fisher Scientific launched the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit, which is designed to safely collect saliva for research. Such initiatives also contribute to the growth of the market.
Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the high cost of collection devices may impede the growth of the market.
Saliva Collection and Diagnostics Industry Segmentation
As per the scope of this report, the saliva collection and diagnosis is a transport and collection system used for collecting clinical specimens for diagnostic purposes. The Saliva Collection and Diagnosis Market is Segmented by Site of Collection (Parotid Gland Collection, Submandibular Collection, and Minor Salivary Glands Collection), By Application (Diagnostic Laboratories, Forensic and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD Million) for the above segments. The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in USD million for the above segments.
| By Site of Collection | |
| Parotid Gland Collection | |
| Submandibular collection | |
| Minor Salivary Glands Collection |
| By Application | |
| Diagnostic Laboratories | |
| Forensics | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Saliva Collection and Diagnosis Market Size Summary
The saliva collection and diagnostics market is experiencing significant growth, driven by the increasing demand for non-invasive and self-saliva-based tests, particularly in the wake of the COVID-19 pandemic. The pandemic has highlighted the need for safe and effective diagnostic methods, creating lucrative opportunities for the market. The rising prevalence of infectious diseases globally has further propelled the demand for saliva-based diagnostics, as these methods offer a painless and efficient way to screen for various conditions. Additionally, the market is benefiting from the approval of new products and initiatives by both public authorities and private companies, which are expanding the applications of saliva collection in areas such as cancer and heart disease risk assessment.
North America is expected to hold a significant share of the market, supported by the increasing prevalence of chronic and infectious diseases and the launch of innovative products by key market players. The region's demand for saliva collection and diagnostics is further bolstered by the presence of advanced diagnostic laboratories and a growing preference for non-invasive testing methods. The market is moderately competitive, with major players like Thermo Fisher Scientific, Neogen Corporation, and Abbott leading the charge. Strategic partnerships and product launches continue to drive market expansion, ensuring that saliva collection and diagnostics remain a vital component of modern healthcare solutions.
Global Saliva Collection and Diagnosis Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Infectious Diseases Among the Population
-
1.2.2 Rising Application of Non- Invasive Saliva testing as a Replacement of Blood Testing
-
-
1.3 Market Restraints
-
1.3.1 High Costs of Collection Devices
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value -USD million)
-
2.1 By Site of Collection
-
2.1.1 Parotid Gland Collection
-
2.1.2 Submandibular collection
-
2.1.3 Minor Salivary Glands Collection
-
-
2.2 By Application
-
2.2.1 Diagnostic Laboratories
-
2.2.2 Forensics
-
2.2.3 Others
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Saliva Collection and Diagnosis Market Size FAQs
What is the current Global Saliva Collection and Diagnosis Market size?
The Global Saliva Collection and Diagnosis Market is projected to register a CAGR of 10.10% during the forecast period (2024-2029)
Who are the key players in Global Saliva Collection and Diagnosis Market?
ThermoFisher Scientific, Abbott, Neogen Corporation, Sarstedt AG&Co.KG- and Autogen Inc are the major companies operating in the Global Saliva Collection and Diagnosis Market.
